EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective

Jessica Nulty, Hanish Anand, Anil Dhawan iD

Stem Cells Translational Medicine · 15.03.2024 · 13 (3) · 204-218

DOI: 10.1093/stcltm/szad084 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 16.12.2023. Verfasst von Jessica Nulty und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dhawan Lab at the Mowat Labs, Institute of Liver Studies, King's College London at King's College Hospital, London, UK. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthotopic liver transplantation (OLT) is the current standard of care for both chronic and acute terminal liver disease. However, a major limitation of this treatment is the shortage of healthy donor organs and the need for life-long immunosuppression to prevent graft rejection. Hepatocyte transplantation (HTx) has emerged as a promising, alternative therapeutic approach to either replace OLT or to act as a bridge until a donor liver becomes available thus reducing waiting list mortality. HTx involves the infusion and engraftment of human hepatocytes, typically isolated from organs unsuitable for OLT, into recipient liver parenchyma to carry out the missing hepatic function of the native cells. HTx is less invasive than OLT and can be performed repeatedly if required. The safety of clinical HTx has been shown and treatment results are promising, especially in patients with liver-based metabolic disorders. Nevertheless, HTx has failed to become the standard of care treatment for such disorders. This review aims to evaluate the progress that has been made within the field of HTx over the last 30 years and identify potential shortcomings within the approach which may be hindering its routine clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiver DiseasesHumansLiving DonorsHepatocytes

Stichwörter der Autor:innen

acute liver failurecell therapyhepatocyte transplantationliver-based metabolic disorders

Autor:innen und Institutionen

  • Dhawan Lab at the Mowat Labs, Institute of Liver Studies, King's College London at King's College Hospital, London, UK.
  • Paediatric Liver GI and Nutrition Centre, King's College Hospital, London, UK.

ORCID-Profile: Anil Dhawan

Zitieren

APA

Nulty, J., Anand, H., & Dhawan, A. (2024). Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective. Stem Cells Translational Medicine, 13(3), 204-218. https://doi.org/10.1093/stcltm/szad084

Vancouver

Nulty J, Anand H, Dhawan A. Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective. Stem Cells Translational Medicine. 2024;13(3):204-218. doi:10.1093/stcltm/szad084

BibTeX
@article{Nulty2024,
  author = {Nulty, Jessica and Anand, Hanish and Dhawan, Anil},
  title = {Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective},
  journal = {Stem Cells Translational Medicine},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {204--218},
  doi = {10.1093/stcltm/szad084}
}
Kostenlos starten →